Who owns Milestone Pharmaceuticals Inc?
- Ticker: MIST
- CUSIP Number: 59935v107
Tip: Access positions for across all investors
Analyze quarterly positions in Milestone Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Milestone Pharmaceuticals stock
Who bought or sold Milestone Pharmaceuticals Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BlackRock | 5.0M | $8.9M | 79% | Mar 2024 |
|
Millennium Management | 2.9M | $5.1M | 65% | Mar 2024 |
|
Alta Fundamental Advisers | 2.4M | $4.2M | 102% | Mar 2024 |
|
Lion Point Capital | 2.3M | $4.1M | 39% | Mar 2024 |
|
Citadel Advisors | 2.3M | $4.1M | 852% | Mar 2024 |
|
OrbiMed Advisors | 2.0M | $3.6M | 100% | Mar 2024 |
|
Nantahala Capital Management | 1.8M | $3.1M | 100% | Mar 2024 |
|
Goldman Sachs Group | 1.4M | $2.4M | 0% | Mar 2024 |
|
Bleichroeder | 1.3M | $2.2M | 0% | Dec 2023 |
|
Altium Capital Management | 1.2M | $2.2M | 100% | Mar 2024 |
|
Morgan Stanley | 820k | $1.5M | 17% | Mar 2024 |
|
Velan Capital Investment Management | 650k | $1.2M | 100% | Mar 2024 |
|
BML Capital Management | 606k | $1.1M | 37% | Mar 2024 |
|
Monashee Investment Management | 500k | $895k | 100% | Mar 2024 |
|
Ikarian Capital | 466k | $834k | 1% | Mar 2024 |
|
Boxer Capital | 309k | $553k | 0% | Mar 2024 |
|
Bank Of Montreal | 273k | $787k | 100% | Mar 2024 |
|
ADAR1 Capital Management | 203k | $362k | 100% | Mar 2024 |
|
Ancora Advisors | 60k | $107k | 20% | Mar 2024 |
|
Envestnet Asset Management | 52k | $93k | 173% | Mar 2024 |
|
Dimensional Fund Advisors | 40k | $71k | -46% | Mar 2024 |
|
Boothbay Fund Management | 31k | $55k | 12% | Mar 2024 |
|
Northern Trust | 28k | $51k | 100% | Mar 2024 |
|
Clear Creek Financial Management | 25k | $45k | -21% | Mar 2024 |
|
Pvg Asset Management | 19k | $32k | 25% | Dec 2023 |
|
Virtu Financial | 19k | $31k | 100% | Dec 2023 |
|
Geode Capital Management | 18k | $32k | 0% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 17k | $30k | 177% | Mar 2024 |
|
Beta Wealth | 14k | $24k | 0% | Dec 2023 |
|
XTX Topco | 13k | $24k | 100% | Mar 2024 |
|
Creative Planning | 13k | $23k | 0% | Mar 2024 |
|
Federation des caisses Desjardins du Quebec | 11k | $19k | 100% | Mar 2024 |
|
Valeo Financial Advisors | 10k | $17k | 0% | Mar 2024 |
|
Advisor Group Holdings | 6.0k | $11k | -57% | Mar 2024 |
|
National Bank Of Canada /fi/ | 3.9k | $6.8k | 0% | Dec 2023 |
|
UBS Group | 2.6k | $4.7k | 100% | Mar 2024 |
|
Simplex Trading | 478.00 | $0 | -56% | Mar 2024 |
|
ICA Group Wealth Management | 200.00 | $358.000000 | 0% | Mar 2024 |
|
Qube Research & Technologies | 194.00 | $347.007800 | 0% | Mar 2024 |
|
Barclays | 100.00 | $0 | -100% | Mar 2024 |
|
Oliver Lagore Vanvalin Investment Group | 100.00 | $179.000000 | 0% | Mar 2024 |
|
Who sold out of Milestone Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
VR Adviser | Dec 2023 | 925k | $1.5M |
Jpmorgan Chase & Co | Dec 2023 | 11k | $18k |